Larvol Delta - A-Phase-I-Randomized-DoubleBlind-PlaceboControlled-Study-to-Evaluate-the-Safety-and-Tolerability-of-Single-and-Multiple-Doses-of-ALT001-in-Healthy-Chinese-Subjects

ALT001 - Beijing Darwin Cell Biotech

https://www.chictr.org.cn/showproj.html?proj=310147

Apr 23, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next